ADI vs SNSE · P/E 61, rev $11.02B vs $18.6M cap
Analog Devices Inc (ADI) versus Sensei Biotherapeutics Inc (SNSE) — a side-by-side from cached financials, not a winner call.
Analog Devices Inc (ADI) is a semiconductors company listed on NASDAQ.
Sensei Biotherapeutics Inc (SNSE) is a biotechnology company listed on NASDAQ.
Latest reported ADI revenue for 2025-11-01 was $11.02B. Net income was $2.27B. ADI currently screens at market cap $201.87B and trailing P/E 61.5.
SNSE does not have a complete income-statement cache yet.
ADI currently screens at market cap $201.87B and trailing P/E 61.5. SNSE currently screens at market cap $18.6M.
Not investment advice. Open the ADI and SNSE stock pages for the full models.
Not investment advice.